tumor immunology Flashcards

(41 cards)

1
Q

Tumor

A

cells with uncontrolled cell growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cancer

A

when a tumor continues to grow and invade healthy tissue.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Oncology

A

the study of tumors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Benin tumors

A

localized, encapsulated, limited size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Malignant tumors

A

continue to increase in size, invade adjacent tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Metastasis

A

enter the circulation and spread

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Carcinoma

A

endodermal/ ectodermal origin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Sarcoma

A

other cell types : mesodermal origin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Leukaemia

A

circulating cells of the immune system

Hematopoietic origin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Lymphoma

A

solid lymphoid tissue

Hematopoietic origin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Myeloma

A

bone marrow (plasma cell)

Hematopoietic origin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Metastasis

A

spread to distant organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Normal Cell Growth promoting

A

Proto-oncogenes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Normal Cell Growth restricting

A

Tumor-suppressor genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Molecular Basis of Cancer

A

Mutation of proto-oncogenes to oncogenes

Altered tumor-suppressor genes:
* p53 mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Colorectal cancer

A

successive mutations of several (5-6) independent genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Burkitt’s lymphoma

A

Gene Translocation

Expression of MYC gene is altered

associated with a viral infection – Epstein Barr virus

18
Q

Failure of the immune system ->

19
Q

What are tumor antigens

A
  1. Tumor Specific Antigens (TSAs)

2. Tumor Associated Antigens (TAAs)

20
Q

Tumor Specific Antigens (TSAs)

A

found only on cancer cells

may arise due to: 

  • Mutation (Mutated P53)
  • Viral antigens (ooncogenic viruses)
21
Q

Tumor Associated Antigens (TAAs)

A

expressed only at certain stage of differentiation

or

Over expression of a normal antigen

22
Q

Alpha-fetoprotein (AFP)

A

secreted by fetal liver

23
Q

Carcino-embryonic antigen (CEA )

A

Found in the gut, liver and pancreas of fetus. Detected at low level in healthy adults

24
Q

Cancer/testis antigen: (CT antigen)

A

expressed on immature sperm cells or trophoblasts ( in early embryo) but not is somatic cells

25
Melanoma-associated antigen (MAGE)
normally expressed on cells of testis (immunologically privileged site)
26
How Tumor Avoid Immune Attack
* MHC I down-regulated – loss of CTL (CD8) * Antigen-less variants OR antigen variant (mutated) * Antigen masking by sialic acid containing mucopolysaccharides * Lack of co-stimulatory molecules (B7) – T cell anergy * FasL expression – T cell apoptosis * TGF-β production: suppress Th1 and promote T-reg * Suppress the immune system by recruiting T-reg – which produce down regulating cytokines, TGF-β , IL-10 * Manipulating/ shedding – MIC (MHC I associated chain or Stress induced molecules (known as Killer activating ligand) * Cancer of privileged sites
27
TGF-β, IL-10
suppresses auto-reactive T cells by TREG
28
High frequency of Treg
indicates a poor prognosis
29
Abnormally high level of monoclonal Ig
indicate a plasma cell tumor
30
Detection of alpha-Fetoprotein ( AFP)
associated with liver cancer
31
Carcinoembryonic antigen (CEA)
indicate malignancy – several, colorectal, pancreas etc
32
Prostate-specific antigen (PSA)
indicate prostate cancer
33
Cancer antigen -125 (CA-125)
ssociated with ovarian cancer, uterine (fallopian) tubes, endometrium (lining of the uterus), lung, breast, and gastrointestinal tract
34
Radiolabeled Monoclonal Antibody B72.3
recognizes all human carcinomas – used in tumor localization
35
IFN-alpha
NK cell activation
36
IFN-gamma
activates CTL, up-regulates MHC expression
37
IL-2
T cell, NK cell proliferation
38
Increasing co-stimulation
Anti-CTLA4 monoclonal antibodies
39
BCG – induce inflammation
bladder cancer therapy
40
Monoclonal antibodies
target the immunosuppressive mediators secreted by tumor *** anti-TGF-beta
41
Anti-tumor monoclonal antibodies, with or without conjugation to toxic drug, radiation
immunotoxins